☆ 4.6 Editorial Material

Cardiorenal risk reduction guidance in diabetes: can we reach consensus?

LANCET DIABETES & ENDOCRINOLOGY (2020)

Journal

LANCET DIABETES & ENDOCRINOLOGY

Volume 8, Issue 5, Pages 357-360

Publisher

ELSEVIER SCIENCE INC

DOI: 10.1016/S2213-8587(20)30062-0

Keywords

-

Categories

Endocrinology & Metabolism

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6

Not enough ratings

Secondary Ratings

Novelty

-

Significance

-

Scientific rigor

-

Rate this paper

Recommended

Editorial Material Cardiac & Cardiovascular Systems

The residual cardiorenal risk in type 2 diabetes

Dario Giugliano, Maria Ida Maiorino, Giuseppe Bellastella, Katherine Esposito

Summary: The commentary discusses the concepts of removed and residual risks in conditioning the cardiorenal outlook of patients with type 2 diabetes. The study highlights the significant role of newer antihyperglycemic drugs, especially SGLT-2i, in reducing cardiovascular events and the progression of diabetic kidney disease.

CARDIOVASCULAR DIABETOLOGY (2021)

Add to Collection

Article Veterinary Sciences

Rabies surveillance in Madagascar from 2011 to 2021: can we reach the target?

Soa Fy Andriamandimby, Marie Hermelienne Volasoa, Nivohanitra Perle Razafindraibe, Dany Bakoly Ranoaritiana, Mino Harimbola Razafindramparany, Theophile Rafisandratantsoa, Lalaina Arivony Nomenjanahary, Naltiana Rakotondrabe, Mamitiana Aime Andriamananjara, Helene Guis, Vincent Lacoste, Anou Dreyfus

Summary: This study summarizes human and animal rabies surveillance activities in Madagascar from 2011 to 2021. The findings suggest that rabies is endemic in Madagascar and cases are substantially underreported. It is crucial to understand the reasons for underreporting and prioritize rabies surveillance, prevention, and control measures.

FRONTIERS IN VETERINARY SCIENCE (2023)

Add to Collection

Article Public, Environmental & Occupational Health

Hepatitis C mortality trends in San Francisco: can we reach elimination targets?

Ali Mirzazadeh, Shelley N. Facente, Katie Burk, James G. Kahn, Meghan D. Morris

Summary: This study estimated and compared HCV-related mortality rates in San Francisco from 1999 to 2019, finding a decrease in mortality rates among most subgroups between 2015 and 2019. Projections suggest that San Francisco is likely to achieve a 65% reduction in HCV-related mortality by 2030 or earlier.

ANNALS OF EPIDEMIOLOGY (2022)

Add to Collection

Article Surgery

Modified Delphi Technique to Identify Management of Aesthetic Breast Augmentation: Will We Reach a Consensus?

Paolo Montemurro, Mubashir Cheema, Per Heden

Summary: This study investigated the practices of 72 plastic surgeons with a specialist interest in aesthetic breast surgery. The results showed that 65.1% of surgeons commonly use breast width as the basis for implant selection, and most surgeons use silicone implants with a volume range of 250 to 350 cc. Opinions varied on controversial issues. This study helps clarify the decision-making process of expert surgeons in aesthetic breast surgery.

PLASTIC AND RECONSTRUCTIVE SURGERY (2023)

Add to Collection

Review Cardiac & Cardiovascular Systems

Immunomodulatory Approaches in Diabetes-Induced Cardiorenal Syndromes

Lama A. Ammar, Mohamad Nahlawi, Nizar W. Shayya, Hilda E. Ghadieh, Nadim S. Azar, Frederic Harb, Assaad A. Eid

Summary: Immunomodulatory approaches involve interventions that modulate host immune responses instead of targeting the disease itself, aiming for disease prevention or treatment. Cardiorenal syndrome defines disorders of the heart and kidneys, with both organs capable of initiating disease in the other through various pathways. Understanding how immunomodulatory approaches are implemented in diabetes-induced cardiovascular and renal diseases is crucial for regenerative medicine.

FRONTIERS IN CARDIOVASCULAR MEDICINE (2021)

Add to Collection

Article Chemistry, Multidisciplinary

Improving the intrinsic activity of electrocatalysts for sustainable energy conversion: where are we and where can we go?

Nitish Govindarajan, Georg Kastlunger, Hendrik H. Heenen, Karen Chan

Summary: With the looming climate crisis, there is an urgent need to transition to sustainable production of fuels and chemicals using renewable energy through electrochemical conversion. Adjusting components of the electrochemical environment like electrolyte, cations, and buffering anions can greatly enhance catalytic activity and bring us a step closer to optimizing electrochemical pathways for sustainable energy conversion.

CHEMICAL SCIENCE (2021)

Add to Collection

Editorial Material Urology & Nephrology

Potential cardiorenal benefits of efpeglenatide in diabetes

Jacques Ma, Mark E. Cooper

Summary: Building on previous cardiovascular outcome trials with glucagon-like peptide 1 receptor agonists, the AMPLITUDE-O trial reported significant improvements in major adverse cardiovascular and kidney outcomes with efpeglenatide in type 2 diabetes. A longer-term trial with dose-dependent analysis on kidney outcome components will better define the effects of efpeglenatide in the diabetic kidney.

NATURE REVIEWS NEPHROLOGY (2021)

Add to Collection

Review Endocrinology & Metabolism

Glucose variability and diabetes complications: Risk factor or biomarker? Can we disentangle the Gordian Knot''?

Louis Monnier, Claude Colette, David Owens

Summary: Variability in glucose homeostasis plays a significant role in diabetes complications, especially in relation to hypoglycemic events. It is important to avoid excessive glucose fluctuations within a day and to understand that variability in glucose homeostasis is not only associated with cardiovascular events but also a causative factor for hypoglycemia.

DIABETES & METABOLISM (2021)

Add to Collection

Article Engineering, Environmental

Can we migrate COVID-19 spreading risk?

Qingyan Chen

Summary: The paper highlights the potential underestimation of SARS-CoV-2 transmission through small droplets or aerosols, and suggests using masks and partition screens on airplanes and in restaurants to reduce infection risks. Advanced ventilation systems like personalized ventilation and displacement ventilation are also recommended for transportation and buildings.

FRONTIERS OF ENVIRONMENTAL SCIENCE & ENGINEERING (2021)

Add to Collection

Review Biochemistry & Molecular Biology

The Genetics of Diabetes: What We Can Learn from Drosophila

Francesco Liguori, Elisa Mascolo, Fiammetta Verni

Summary: Diabetes mellitus is a heterogeneous disease characterized by high blood sugar caused by a combination of genetic and environmental factors, with both monogenic and multigenic forms. While many putative causative genes have been identified, a large percentage of cases remain undiagnosed, indicating a need for further research to identify causal variants of diabetes.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Add to Collection

Article Biochemistry & Molecular Biology

How accurately can we assess zoonotic risk?

Michelle Wille, Jemma L. Geoghegan, Edward C. Holmes

Summary: Identifying animal reservoirs of zoonotic viruses is crucial in understanding disease emergence. Studies attempting zoonotic risk assessment have increased, but virological data used in these analyses are incomplete and biased. Virus surveillance at the human-animal interface may be more productive than relying on existing virological data.

PLOS BIOLOGY (2021)

Add to Collection

Review Nutrition & Dietetics

The Carbohydrate Threshold in Pregnancy and Gestational Diabetes: How Low Can We Go?

Arianne Sweeting, Jovana Mijatovic, Grant D. Brinkworth, Tania P. Markovic, Glynis P. Ross, Jennie Brand-Miller, Teri L. Hernandez

Summary: Recent studies suggest that the optimal carbohydrate intake during pregnancy is in the range of 47-70% of total energy intake. Further research is needed to investigate the effects of low carbohydrate diets on pregnant women and fetal development.

NUTRIENTS (2021)

Add to Collection

Review Endocrinology & Metabolism

SGLT2 Inhibition in Type 1 Diabetes with Diabetic Kidney Disease: Potential Cardiorenal Benefits Can Outweigh Preventable Risk of Diabetic Ketoacidosis

Hongyan Liu, Vikas S. Sridhar, Bruce A. Perkins, Julio Rosenstock, David Z. Cherney

Summary: SGLT2 inhibitors have shown cardiovascular benefits and kidney protection in patients with T2DM, but may increase the risk of DKA in T1DM patients. Further research is needed to determine the kidney protective effects in T1DM patients and quantify the risk of DKA.

CURRENT DIABETES REPORTS (2022)

Add to Collection

Article Endocrinology & Metabolism

Artificial intelligence in diabetes mellitus and endocrine diseases - what can we expect?

Ioannis T. Oikonomakos, Charlotte Steenblock, Stefan R. Bornstein

Summary: Artificial intelligence has brought revolutionary changes to various fields in medicine and research. The complex and interconnected nature of the endocrine system makes it an ideal area to further capitalize on the potential benefits of artificial intelligence.

NATURE REVIEWS ENDOCRINOLOGY (2023)

Add to Collection

Article Nutrition & Dietetics

Diabetes Risk Reduction Diet and Endometrial Cancer Risk

Giovanna Esposito, Francesca Bravi, Diego Serraino, Fabio Parazzini, Anna Crispo, Livia S. A. Augustin, Eva Negri, Carlo La Vecchia, Federica Turati

Summary: The study found that following a diabetes risk reduction diet may reduce the risk of endometrial cancer. Combining high vegetable consumption with high adherence to the DRRD may offer additional benefits in preventing endometrial cancer.

NUTRIENTS (2021)

Add to Collection

Article Transplantation

Extrapolated longer-term effects of the DAPA-CKD trial: a modelling analysis

Phil McEwan, Rebecca Boyce, Juan Jose Garcia Sanchez, C. David Sjostrom, Bergur Stefansson, Stephen Nolan, Ricardo Correa-Rotter, Peter Rossing, Glenn M. Chertow, John J. McMurray, David C. Wheeler, Hiddo J. L. Heerspink

Summary: The DAPA-CKD trial demonstrated that dapagliflozin has significant benefits in patients with chronic kidney disease and albuminuria. Using a Markov model, it was predicted that dapagliflozin treatment would lead to longer time in lower CKD stages, reduced mortality, and fewer complications such as heart failure and kidney function decline.

NEPHROLOGY DIALYSIS TRANSPLANTATION (2023)

Add to Collection

Article Cardiac & Cardiovascular Systems

Sex Differences in Characteristics, Outcomes, and Treatment Response With Dapagliflozin Across the Range of Ejection Fraction in Patients With Heart Failure: Insights From DAPA-HF and DELIVER

Xiaowen Wang, Muthiah Vaduganathan, Brian L. Claggett, Sheila M. Hegde, Maria Pabon, Ian J. Kulac, Orly Vardeny, Eileen O'Meara, Shelley Zieroth, Tzvetana Katova, Martina M. McGrath, Anne-Catherine Pouleur, Pardeep S. Jhund, Akshay S. Desai, Silvio E. Inzucchi, Mikhail N. Kosiborod, Rudolf A. de Boer, Lars Kober, Marc S. Sabatine, Felipe A. Martinez, Piotr Ponikowski, Sanjiv J. Shah, Adrian F. Hernandez, Anna Maria Langkilde, John J. McMurray, Scott D. Solomon, Carolyn S. P. Lam

Summary: This study analyzed the efficacy and safety of sodium-glucose cotransporter-2 inhibitors in the treatment of heart failure, and assessed the impact of sex on their effectiveness and safety. The study found that, after adjusting for baseline differences, women had fewer cardiovascular and all-cause deaths, as well as lower rates of HF hospitalizations and total events, compared to men. There were no sex-related differences in adverse events or drug discontinuation. Therefore, sex does not modify the treatment effect of sodium-glucose cotransporter-2 inhibitors.

CIRCULATION (2023)

Add to Collection

Article Transplantation

Analysis of on-treatment cancer safety events with daprodustat versus conventional erythropoiesis-stimulating agents-post hoc analyses of the ASCEND-ND and ASCEND-D trials

Ajay K. Singh, Finnian R. Mc Causland, Brian L. Claggett, Christoph Wanner, Andrzej Wiecek, Michael B. Atkins, Kevin Carroll, Vlado Perkovic, John J. McMurray, Janet Wittes, Steven Snapinn, Allison Blackorby, Amy Meadowcroft, Tara Barker, Tara DiMino, Stephen Mallett, Alexander R. Cobitz, Scott D. Solomon

Summary: Different dosing intervals were used in the study, which resulted in different risks of cancer-related adverse events for daprodustat compared to darbepoetin in patients with CKD. However, no excess risk of cancer-related adverse events was observed in dialysis patients.

NEPHROLOGY DIALYSIS TRANSPLANTATION (2023)

Add to Collection

Article Cardiac & Cardiovascular Systems

Population-Level Implications of Sodium-Glucose Cotransporter-2 Inhibitors for Heart Failure With Preserved Ejection Fraction in the US

Khawaja M. M. Talha, Javed Butler, Stephen J. J. Greene, Rahul Aggarwal, Stefan D. D. Anker, Brian L. Claggett, Scott D. D. Solomon, John J. V. McMurray, Muthiah Vaduganathan, Gregg C. C. Fonarow

Summary: The expansion of SGLT-2 inhibitor use in patients with HF and LVEF more than 40% following the EMPEROR-Preserved and the DELIVER trials has significant implications in the US. This study quantified the potential impact of reducing worsening HF events with SGLT-2 inhibitors in individuals with LVEF more than 40% at the population level in the US. The findings suggest that optimal implementation of SGLT-2 inhibitor therapy in this population could prevent/postpone approximately 250,000 worsening HF events over 3 years in the US.

JAMA CARDIOLOGY (2023)

Add to Collection

Article Cardiac & Cardiovascular Systems

Associations Between New York Heart Association Classification, Objective Measures, and Long-term Prognosis in Mild Heart Failure A Secondary Analysis of the PARADIGM-HF Trial

Luis E. Rohde, Andre Zimerman, Muthiah Vaduganathan, Brian L. Claggett, Milton Packer, Akshay S. Desai, Michael Zile, Jean Rouleau, Karl Swedberg, Martin Lefkowitz, Victor Shi, John J. V. McMurray, Scott D. Solomon

Summary: The study assessed the variation in NYHA classification over time, the association between NYHA class and an objective measure of HF severity (NT-proBNP level), and their association with mid-term prognosis. Results showed that NYHA classification could be limited to differentiate mild forms of HF as patients in NYHA class I and II overlapped substantially in objective measures and mid-term prognosis.

JAMA CARDIOLOGY (2023)

Add to Collection

Article Cardiac & Cardiovascular Systems

Efficacy of pulmonary artery pressure monitoring in patients with chronic heart failure: a meta-analysis of three randomized controlled trials

Pascal R. D. Clephas, Sumant P. Radhoe, Eric Boersma, John Gregson, Pardeep S. Jhund, William T. Abraham, John J. McMurray, Rudolf A. de Boer, Jasper J. Brugts

Summary: A meta-analysis of large randomized trials showed that remote monitoring of pulmonary artery pressure and adjusting treatment can reduce hospital admissions for heart failure.

EUROPEAN HEART JOURNAL (2023)

Add to Collection

Article Cardiac & Cardiovascular Systems

Heart failure, peripheral artery disease, and dapagliflozin: a patient-level meta-analysis of DAPA-HF and DELIVER

Jawad H. Butt, Toru Kondo, Mingming Yang, Pardeep S. Jhund, Kieran F. Docherty, Muthiah Vaduganathan, Brian L. Claggett, Adrian F. Hernandez, Carolyn S. P. Lam, Silvio E. Inzucchi, Felipe A. Martinez, Rudolf A. de Boer, Mikhail N. Kosiborod, Akshay S. Desai, Lars Kober, Piotr Ponikowski, Marc S. Sabatine, Sanjiv J. Shah, Natalia Zaozerska, Ulrica Wilderang, Olof Bengtsson, Scott D. Solomon, John J. McMurray

Summary: This study aimed to assess the efficacy and safety of dapagliflozin in patients with heart failure, particularly in those with peripheral artery disease (PAD). The results showed that dapagliflozin was equally effective in patients with and without PAD and did not increase the risk of amputation.

EUROPEAN HEART JOURNAL (2023)

Add to Collection

Article Cardiac & Cardiovascular Systems

Dapagliflozin and diuretic utilization in heart failure with mildly reduced or preserved ejection fraction: the DELIVER trial

Safia Chatur, Muthiah Vaduganathan, Brian Claggett, Orly Vardeny, Akshay S. Desai, Pardeep S. Jhund, Rudolf A. de Boer, Carolyn S. P. Lam, Mikhail N. Kosiborod, Sanjiv J. Shah, Felipe Martinez, Silvio E. Inzucchi, Adrian F. Hernandez, Tariq Haddad, Sumeet S. Mitter, Zi Michael Miao, Magnus Petersson, Anna Maria Langkilde, John J. McMurray, Scott D. Solomon

Summary: In this study, the safety and efficacy of dapagliflozin were evaluated according to different diuretic therapies and its influence on diuretic use. The results showed that dapagliflozin had consistent clinical benefits in terms of reducing heart failure worsening and cardiovascular death across different diuretic categories and doses, with a similar safety profile. Dapagliflozin also significantly reduced the need for loop diuretics over time.

EUROPEAN HEART JOURNAL (2023)

Add to Collection

Correction Biochemistry & Molecular Biology

Dapagliflozin in heart failure with improved ejection fraction: a prespecified analysis of the DELIVER trial (vol 28, 2504, 2022)

Orly Vardeny, James C. C. Fang, Akshay S. S. Desai, Pardeep S. S. Jhund, Brian Claggett, Muthiah Vaduganathan, Rudolf A. A. de Boer, Adrian F. F. Hernandez, Carolyn S. P. Lam, Silvio E. E. Inzucchi, Felipe A. A. Martinez, Mikhail N. N. Kosiborod, David DeMets, Eileen O'Meara, Shelley Zieroth, Josep Comin-Colet, Jaroslaw Drozdz, Chern-En Chiang, Masafumi Kitakaze, Magnus Petersson, Daniel Lindholm, Anna Maria Langkilde, John J. V. McMurray, Scott D. D. Solomon

NATURE MEDICINE (2023)

Add to Collection

Article Cardiac & Cardiovascular Systems

Physical Frailty and Use of Guideline-Recommended Drugs in Patients With Heart Failure and Reduced Ejection Fraction

Toru Kondo, Takuji Adachi, Kiyonori Kobayashi, Takahiro Okumura, Hideo Izawa, Toyoaki Murohara, John J. V. McMurray, Sumio Yamada

Summary: The severity of physical frailty is associated with the use of evidence-based pharmacological therapy for heart failure with reduced ejection fraction and has an impact on prognosis. Prescription rates of guideline-recommended therapy decreased as physical frailty increased, and underprescription of guideline-recommended therapy may contribute to poor prognosis in physically frail patients.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2023)

Add to Collection

Article Cardiac & Cardiovascular Systems

A 20-year population study of peripartum cardiomyopathy

Alice M. Jackson, Mark Macartney, Katriona Brooksbank, Carolyn Brown, Dana Dawson, Mark Francis, Alan Japp, Vera Lennie, Stephen J. Leslie, Thomas Martin, Paul Neary, Sowmya Venkatasubramanian, Debra Vickers, Robin A. Weir, John J. Mcmurray, Pardeep S. Jhund, Mark C. Petrie

Summary: This study investigated the incidence, risk factors, morbidity and mortality of peripartum cardiomyopathy (PPCM) in Scotland from 1998 to 2017, and found that PPCM poses considerable risks to mothers and children. There should be a lower threshold for investigating women at risk, and long-term follow-up should be considered even in cases of apparent recovery.

EUROPEAN HEART JOURNAL (2023)

Add to Collection

Review Cardiac & Cardiovascular Systems

2022 Joint ESC/EACTS review of the 2018 guideline recommendations on the revascularization of left main coronary artery disease in patients at low surgical risk and anatomy suitable for PCI or CABG

Robert A. Byrne, Stephen Fremes, Davide Capodanno, Martin Czerny, Torsten Doenst, Jonathan R. Emberson, Volkmar Falk, Mario Gaudino, John J. Mcmurray, Roxana Mehran, Milan Milojevic, Miguel Sousa Uva

Summary: In October 2021, the ESC and EACTS established a task force to review the 2018 guidelines on myocardial revascularization for patients with LM disease. The task force suggested updated recommendations for revascularization modality, stating that both CABG and PCI are clinically reasonable options for stable patients with LM disease. The task force also acknowledged knowledge gaps and emphasized the need for more data.

EUROPEAN HEART JOURNAL (2023)

Add to Collection

Review Biochemistry & Molecular Biology

Recent successes in heart failure treatment

Carolyn S. P. Lam, Kieran F. Docherty, Jennifer E. Ho, John J. V. McMurray, Peder L. Myhre, Torbjorn Omland

Summary: Recent advances in heart failure have greatly improved survival and outcomes for patients with reduced ejection fraction. Novel genetic and molecular approaches have also shown promise in managing previously incurable conditions. However, there are still significant gaps and disparities in care, implementation, and understanding of the socioeconomic determinants of outcomes. Ongoing clinical trials and technological advancements provide hope for addressing these issues in the future.

NATURE MEDICINE (2023)

Add to Collection

Review Cardiac & Cardiovascular Systems

2022 Joint ESC/EACTS review of the 2018 guideline recommendations on the revascularization of left main coronary artery disease in patients at low surgical risk and anatomy suitable for PCI or CABG

Robert A. Byrne, Stephen Fremes, Davide Capodanno, Martin Czerny, Torsten Doenst, Jonathan R. Emberson, Volkmar Falk, Mario Gaudino, John J. Mcmurray, Roxana Mehran, Milan Milojevic, Miguel Sousa Uva

Summary: In October 2021, the ESC and EACTS established a Task Force to review recommendations on myocardial revascularization in patients with LM disease. The TF assessed new data, including aggregated data from four randomized trials comparing PCI with CABG. The TF concluded that both treatment options are clinically reasonable based on patient preference, expertise, and local operator volumes, but acknowledged gaps in knowledge and the limitations of the available data.

EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY (2023)

Add to Collection

Correction Cardiac & Cardiovascular Systems

Investigator-reported ventricular arrhythmias and mortality in heart failure with mildly reduced or preserved ejection fraction (vol 44, pg 668, 2023)

James P. Curtain, Carly Adamson, Toru Kondo, Jawad Haider Butt, Akshay S. Desai, Faiez Zannad, Jean L. Rouleau, Luis E. Rohde, Lars Kober, Inder S. Anand, Dirk J. van Veldhuisen, Michael R. Zile, Martin P. Lefkowitz, Scott D. Solomon, Milton Packer, Mark C. Petrie, Pardeep S. Jhund, John J. V. McMurray

EUROPEAN HEART JOURNAL (2023)

Add to Collection

No Data Available

© Peeref 2019-2024. All rights reserved.